Clinical Trials Browser

Recruiting × Recurrence × cabozantinib × Clear all

NCT04204850 2025-12-03

Cabozantinib to Treat Recurrent Liver Cancer Post Transplant

Phase 2 Recruiting

Gastrointestinal

Carcinoma, Hepatocellular, Recurrence

NCT06156410 2025-11-14

Cabozantinib With Ifosfamide in Relapsed/Refractory Sarcomas

Phase 1 Recruiting

Recurrence, Sarcoma, Sarcoma, Ewing, Osteosarcoma